Authors:
DECREMOUX H
BEKRADDA M
MONNET I
SOULIE P
SALTIEL S
MISSET JL
FANDI A
BENSMAINE MA
CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 474-474
Authors:
DECREMOUX H
BEKRADDA M
MONNET I
SOULIE P
SALTIEL S
MISSET JL
FANDI A
BENSMAINE MA
CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 446-446
Authors:
BEKRADDA M
CHATELUT E
CVITKOVIC E
SOULIE P
CANAL P
MISSET JL
DUPONTANDRE G
BENSMAINE MA
BUGAT R
Citation: M. Bekradda et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF THE CARBOPLATIN (CBDCA)OXALIPLATIN (L-OHP) COMBINATION IN PATIENTS (PTS) WITH ADVANCED MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL/, Annals of oncology, 9, 1998, pp. 447-447
Authors:
DUCREUX M
LOUVET C
BEKRADDA M
CVITKOVIC E
Citation: M. Ducreux et al., OXALIPLATIN FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER - FUTURE-DIRECTIONS, Seminars in oncology, 25(2), 1998, pp. 47-53
Authors:
CULINE S
THEODORE C
BEKRADDA M
FARHAT F
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., EXPERIENCE WITH BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) AND ALTERNATINGCISPLATIN, CYCLOPHOSPHAMIDE, DOXORUBICIN (CISCA(II)) VINBLASTINE, BLEOMYCIN (VBIV) REGIMENS OF CHEMOTHERAPY IN POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS, American journal of clinical oncology, 20(2), 1997, pp. 184-188
Authors:
CULINE S
THEODORE C
FARHAT F
BEKRADDA M
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., CISPLATIN-BASED CHEMOTHERAPY AFTER RETROPERITONEAL LYMPH-NODE DISSECTION IN PATIENTS WITH PATHOLOGICAL STAGE-II NONSEMINOMATOUS GERM-CELL TUMORS, Journal of surgical oncology, 61(3), 1996, pp. 195-198
Authors:
FARHAT F
CULINE S
THEODORE C
BEKRADDA M
TERRIERLACOMBE MJ
DROZ JP
Citation: F. Farhat et al., CISPLATIN AND IFOSFAMIDE WITH EITHER VINBLASTINE OR ETOPOSIDE AS SALVAGE THERAPY FOR REFRACTORY OR RELAPSING GERM-CELL TUMOR PATIENTS - THEINSTITUT-GUSTAVE-ROUSSY EXPERIENCE, Cancer, 77(6), 1996, pp. 1193-1197
Authors:
CULINE S
BEKRADDA M
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., TREATMENT OF SARCOMATOID RENAL-CELL CARCINOMA - IS THERE A ROLE FOR CHEMOTHERAPY, European urology, 27(2), 1995, pp. 138-141
Authors:
MOUNEDJIBOUDIAF L
CULINE S
DEVOLDERE G
TERRIERLACOMBE MJ
KATTAN J
CAZIER A
FARHAT F
BEKRADDA M
DROZ JP
Citation: L. Mounedjiboudiaf et al., PRIMARY HIGH-GRADE NON-HODGKIN-LYMPHOMA O F THE PROSTATE WITH A B-CELL ORIGIN - A CASE-REPORT AND REVIEW OF THE LITERATURE, Bulletin du cancer, 81(4), 1994, pp. 334-337
Authors:
FARHAT F
KATTAN J
CULINE S
THEODORE C
TERRIERLACOMBE MJ
GENIN J
MOUNEDJIBOUDIAF L
BEKRADDA M
DROZ JP
Citation: F. Farhat et al., LIPOSARCOMA OF THE SPERMATIC CORD - A CAS E-REPORT AND REVIEW OF THE LITERATURE, Bulletin du cancer, 81(3), 1994, pp. 223-225
Authors:
ABS L
KATTAN J
CULINE S
BEKRADDA M
FARHAT F
DROZ JP
Citation: L. Abs et al., PIPERACILLIN PLUS SULBACTAM POTENTIALLY A SSOCIATED TO VANCOMYCIN ANTIMICROBIAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS TREATED FOR SOLD TUMORS, Bulletin du cancer, 81(10), 1994, pp. 871-876
Authors:
FARHAT F
KATTAN J
CULINE S
BEKRADDA M
DROZ JP
Citation: F. Farhat et al., 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATINU M (FAP REGIMEN) EFFICACY INMETASTATIC ADENOID CYSTIC CARCINOMA - A CASE-REPORT AND REVIEW OF THELITERATURE, Bulletin du cancer, 81(1), 1994, pp. 47-50